Platform Validation: insulin, uricase, and a1at

Successful completion of lab-scale isolation of three key therapeutic proteins including insulin, uricase, and alpha-1 antitrypsin, through a Shared Research Agreement with Washington University in St. Louis. This achievement validates the strength and versatility of rBIO’s underlying synthetic biology platform and engineered cellular systems.